Stock Taper Revenue:: $634 million, exceeding guidance by $9 million but down 8% year-over-year and 4% sequentially.
Gross Margin:: 29.1%, at the high end of guidance, but down 190 basis points year-over-year and 70 basis points sequentially.
Adjusted EBITDA:: $57.5 million (9.1% of revenue), 90 basis points above guidance but down 22% year-over-year.
Net Income:: $29 million, significantly improved from a net loss of $116 million in the prior quarter.
GAAP EPS:: $0.76; Adjusted EPS: $0.39, down from $0.61 year-over-year.
Cash Position:: $53 million in cash and equivalents; total debt at $850 million with a net leverage ratio of 3.3x.
AMN is transitioning from recovery to growth, with a moderate recovery in staffing demand and improved extension rates.
The company is benefiting from diversification across its 20 solutions, positioning itself as a strategic partner for clients.
Strong performance in the Nurse and Allied Solutions segment, with $361 million in revenue, driven by higher Travel Nurse volume and Labor Disruption revenue.
Positive developments in the Physician and Leadership Solutions segment, with a 3% year-over-year growth in Locum Tenens revenue.
The company completed a debt refinancing that improved its financial position and extended debt maturities to 2029.
Q4 Revenue Guidance:: Expected to be between $715 million and $730 million, including approximately $100 million from Labor Disruption support.
Gross Margin Guidance:: Projected between 25.5% and 26%, with a lower outlook due to Labor Disruption impacts.
Adjusted EBITDA Margin:: Expected to be between 6.8% and 7.3%.
The company anticipates modest year-over-year growth in bill rates for Nurse and Allied Staffing in Q4, the first increase in three years.
Declining Metrics:: Gross margin has declined due to unfavorable revenue mix and competitive pressures, particularly in Staffing and Language Services.
Permanent Hiring Decline:: There is a notable drop in permanent hiring activity in the healthcare sector, which may affect future demand.
Competitive Pressures:: The market remains competitive, with some clients showing less motivation to switch vendors, impacting new client acquisition.
Economic Uncertainty:: Potential federal healthcare funding cuts may influence demand for contingent labor, particularly among rural hospitals.
Management indicated that while demand for contingent labor is improving, it is still influenced by pricing strategies from clients.
The company is seeing a shift towards contingent staffing as clients recognize its affordability compared to permanent labor.
There is optimism about the potential for increased bill rates, which could help fill open orders and drive volume.
The demand for Locum Tenens is broad-based, with particular strength in specialties like surgery and hospitalist roles.
Academic medical centers are still lagging behind non-academic systems but are approaching stabilization. This summary encapsulates AMN Healthcare's performance and strategic direction as of Q3 2025, highlighting both opportunities and challenges in the current market landscape.
SOURCE: Q3 2025 EARNINGS CALL TRANSCRIPT